Global T Cell Surface Glycoprotein CD4 Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global T Cell Surface Glycoprotein CD4 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for T Cell Surface Glycoprotein CD4 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for T Cell Surface Glycoprotein CD4 by Country/Region, 2017, 2022 & 2028

2.2 T Cell Surface Glycoprotein CD4 Segment by Type

2.2.1 Forigerimod Acetate

2.2.2 HIV Vaccine 2

2.2.3 Ibalizumab

2.2.4 Others

2.3 T Cell Surface Glycoprotein CD4 Sales by Type

2.3.1 Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2017-2022)

2.3.2 Global T Cell Surface Glycoprotein CD4 Revenue and Market Share by Type (2017-2022)

2.3.3 Global T Cell Surface Glycoprotein CD4 Sale Price by Type (2017-2022)

2.4 T Cell Surface Glycoprotein CD4 Segment by Application

2.4.1 HIV

2.4.2 AIDS

2.4.3 GVHD

2.4.4 SARS

2.4.5 Others

2.5 T Cell Surface Glycoprotein CD4 Sales by Application

2.5.1 Global T Cell Surface Glycoprotein CD4 Sale Market Share by Application (2017-2022)

2.5.2 Global T Cell Surface Glycoprotein CD4 Revenue and Market Share by Application (2017-2022)

2.5.3 Global T Cell Surface Glycoprotein CD4 Sale Price by Application (2017-2022)

3 Global T Cell Surface Glycoprotein CD4 by Company

3.1 Global T Cell Surface Glycoprotein CD4 Breakdown Data by Company

3.1.1 Global T Cell Surface Glycoprotein CD4 Annual Sales by Company (2020-2022)

3.1.2 Global T Cell Surface Glycoprotein CD4 Sales Market Share by Company (2020-2022)

3.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue by Company (2020-2022)

3.2.1 Global T Cell Surface Glycoprotein CD4 Revenue by Company (2020-2022)

3.2.2 Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Company (2020-2022)

3.3 Global T Cell Surface Glycoprotein CD4 Sale Price by Company

3.4 Key Manufacturers T Cell Surface Glycoprotein CD4 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers T Cell Surface Glycoprotein CD4 Product Location Distribution

3.4.2 Players T Cell Surface Glycoprotein CD4 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for T Cell Surface Glycoprotein CD4 by Geographic Region

4.1 World Historic T Cell Surface Glycoprotein CD4 Market Size by Geographic Region (2017-2022)

4.1.1 Global T Cell Surface Glycoprotein CD4 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue by Geographic Region

4.2 World Historic T Cell Surface Glycoprotein CD4 Market Size by Country/Region (2017-2022)

4.2.1 Global T Cell Surface Glycoprotein CD4 Annual Sales by Country/Region (2017-2022)

4.2.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue by Country/Region

4.3 Americas T Cell Surface Glycoprotein CD4 Sales Growth

4.4 APAC T Cell Surface Glycoprotein CD4 Sales Growth

4.5 Europe T Cell Surface Glycoprotein CD4 Sales Growth

4.6 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Growth

5 Americas

5.1 Americas T Cell Surface Glycoprotein CD4 Sales by Country

5.1.1 Americas T Cell Surface Glycoprotein CD4 Sales by Country (2017-2022)

5.1.2 Americas T Cell Surface Glycoprotein CD4 Revenue by Country (2017-2022)

5.2 Americas T Cell Surface Glycoprotein CD4 Sales by Type

5.3 Americas T Cell Surface Glycoprotein CD4 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC T Cell Surface Glycoprotein CD4 Sales by Region

6.1.1 APAC T Cell Surface Glycoprotein CD4 Sales by Region (2017-2022)

6.1.2 APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2017-2022)

6.2 APAC T Cell Surface Glycoprotein CD4 Sales by Type

6.3 APAC T Cell Surface Glycoprotein CD4 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe T Cell Surface Glycoprotein CD4 by Country

7.1.1 Europe T Cell Surface Glycoprotein CD4 Sales by Country (2017-2022)

7.1.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2017-2022)

7.2 Europe T Cell Surface Glycoprotein CD4 Sales by Type

7.3 Europe T Cell Surface Glycoprotein CD4 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa T Cell Surface Glycoprotein CD4 by Country

8.1.1 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Country (2017-2022)

8.1.2 Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2017-2022)

8.2 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type

8.3 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of T Cell Surface Glycoprotein CD4

10.3 Manufacturing Process Analysis of T Cell Surface Glycoprotein CD4

10.4 Industry Chain Structure of T Cell Surface Glycoprotein CD4

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 T Cell Surface Glycoprotein CD4 Distributors

11.3 T Cell Surface Glycoprotein CD4 Customer

12 World Forecast Review for T Cell Surface Glycoprotein CD4 by Geographic Region

12.1 Global T Cell Surface Glycoprotein CD4 Market Size Forecast by Region

12.1.1 Global T Cell Surface Glycoprotein CD4 Forecast by Region (2023-2028)

12.1.2 Global T Cell Surface Glycoprotein CD4 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global T Cell Surface Glycoprotein CD4 Forecast by Type

12.7 Global T Cell Surface Glycoprotein CD4 Forecast by Application

13 Key Players Analysis

13.1 Biotest AG

13.1.1 Biotest AG Company Information

13.1.2 Biotest AG T Cell Surface Glycoprotein CD4 Product Offered

13.1.3 Biotest AG T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Biotest AG Main Business Overview

13.1.5 Biotest AG Latest Developments

13.2 Bristol-Myers Squibb Co

13.2.1 Bristol-Myers Squibb Co Company Information

13.2.2 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product Offered

13.2.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Co Main Business Overview

13.2.5 Bristol-Myers Squibb Co Latest Developments

13.3 CEL-SCI Corp

13.3.1 CEL-SCI Corp Company Information

13.3.2 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product Offered

13.3.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CEL-SCI Corp Main Business Overview

13.3.5 CEL-SCI Corp Latest Developments

13.4 Fountain Biopharma Inc

13.4.1 Fountain Biopharma Inc Company Information

13.4.2 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product Offered

13.4.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Fountain Biopharma Inc Main Business Overview

13.4.5 Fountain Biopharma Inc Latest Developments

13.5 Immupharma Plc

13.5.1 Immupharma Plc Company Information

13.5.2 Immupharma Plc T Cell Surface Glycoprotein CD4 Product Offered

13.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Immupharma Plc Main Business Overview

13.5.5 Immupharma Plc Latest Developments

13.6 Sanofi

13.6.1 Sanofi Company Information

13.6.2 Sanofi T Cell Surface Glycoprotein CD4 Product Offered

13.6.3 Sanofi T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sanofi Main Business Overview

13.6.5 Sanofi Latest Developments

13.7 TaiMed Biologics Inc

13.7.1 TaiMed Biologics Inc Company Information

13.7.2 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product Offered

13.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 TaiMed Biologics Inc Main Business Overview

13.7.5 TaiMed Biologics Inc Latest Developments

13.8 United Biomedical Inc

13.8.1 United Biomedical Inc Company Information

13.8.2 United Biomedical Inc T Cell Surface Glycoprotein CD4 Product Offered

13.8.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 United Biomedical Inc Main Business Overview

13.8.5 United Biomedical Inc Latest Developments

14 Research Findings and Conclusion

Table 1. T Cell Surface Glycoprotein CD4 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. T Cell Surface Glycoprotein CD4 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Forigerimod Acetate

Table 4. Major Players of HIV Vaccine 2

Table 5. Major Players of Ibalizumab

Table 6. Major Players of Others

Table 7. Global T Cell Surface Glycoprotein CD4 Sales by Type (2017-2022) & (K Pcs)

Table 8. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2017-2022)

Table 9. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2017-2022) & ($ million)

Table 10. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2017-2022)

Table 11. Global T Cell Surface Glycoprotein CD4 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global T Cell Surface Glycoprotein CD4 Sales by Application (2017-2022) & (K Pcs)

Table 13. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2017-2022)

Table 14. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2017-2022)

Table 15. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2017-2022)

Table 16. Global T Cell Surface Glycoprotein CD4 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global T Cell Surface Glycoprotein CD4 Sales by Company (2020-2022) & (K Pcs)

Table 18. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Company (2020-2022)

Table 19. Global T Cell Surface Glycoprotein CD4 Revenue by Company (2020-2022) ($ Millions)

Table 20. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Company (2020-2022)

Table 21. Global T Cell Surface Glycoprotein CD4 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers T Cell Surface Glycoprotein CD4 Producing Area Distribution and Sales Area

Table 23. Players T Cell Surface Glycoprotein CD4 Products Offered

Table 24. T Cell Surface Glycoprotein CD4 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global T Cell Surface Glycoprotein CD4 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global T Cell Surface Glycoprotein CD4 Sales Market Share Geographic Region (2017-2022)

Table 29. Global T Cell Surface Glycoprotein CD4 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global T Cell Surface Glycoprotein CD4 Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Country/Region (2017-2022)

Table 33. Global T Cell Surface Glycoprotein CD4 Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas T Cell Surface Glycoprotein CD4 Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2017-2022)

Table 37. Americas T Cell Surface Glycoprotein CD4 Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2017-2022)

Table 39. Americas T Cell Surface Glycoprotein CD4 Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2017-2022)

Table 41. Americas T Cell Surface Glycoprotein CD4 Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2017-2022)

Table 43. APAC T Cell Surface Glycoprotein CD4 Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2017-2022)

Table 45. APAC T Cell Surface Glycoprotein CD4 Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2017-2022)

Table 47. APAC T Cell Surface Glycoprotein CD4 Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2017-2022)

Table 49. APAC T Cell Surface Glycoprotein CD4 Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2017-2022)

Table 51. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2017-2022)

Table 53. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2017-2022)

Table 55. Europe T Cell Surface Glycoprotein CD4 Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2017-2022)

Table 57. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of T Cell Surface Glycoprotein CD4

Table 68. Key Market Challenges & Risks of T Cell Surface Glycoprotein CD4

Table 69. Key Industry Trends of T Cell Surface Glycoprotein CD4

Table 70. T Cell Surface Glycoprotein CD4 Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. T Cell Surface Glycoprotein CD4 Distributors List

Table 73. T Cell Surface Glycoprotein CD4 Customer List

Table 74. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global T Cell Surface Glycoprotein CD4 Sales Market Forecast by Region

Table 76. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC T Cell Surface Glycoprotein CD4 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC T Cell Surface Glycoprotein CD4 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global T Cell Surface Glycoprotein CD4 Sales Market Share Forecast by Type (2023-2028)

Table 88. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global T Cell Surface Glycoprotein CD4 Sales Market Share Forecast by Application (2023-2028)

Table 92. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Application (2023-2028)

Table 94. Biotest AG Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 95. Biotest AG T Cell Surface Glycoprotein CD4 Product Offered

Table 96. Biotest AG T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Biotest AG Main Business

Table 98. Biotest AG Latest Developments

Table 99. Bristol-Myers Squibb Co Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 100. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product Offered

Table 101. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Bristol-Myers Squibb Co Main Business

Table 103. Bristol-Myers Squibb Co Latest Developments

Table 104. CEL-SCI Corp Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 105. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product Offered

Table 106. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. CEL-SCI Corp Main Business

Table 108. CEL-SCI Corp Latest Developments

Table 109. Fountain Biopharma Inc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 110. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product Offered

Table 111. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Fountain Biopharma Inc Main Business

Table 113. Fountain Biopharma Inc Latest Developments

Table 114. Immupharma Plc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 115. Immupharma Plc T Cell Surface Glycoprotein CD4 Product Offered

Table 116. Immupharma Plc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Immupharma Plc Main Business

Table 118. Immupharma Plc Latest Developments

Table 119. Sanofi Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 120. Sanofi T Cell Surface Glycoprotein CD4 Product Offered

Table 121. Sanofi T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Sanofi Main Business

Table 123. Sanofi Latest Developments

Table 124. TaiMed Biologics Inc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 125. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product Offered

Table 126. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. TaiMed Biologics Inc Main Business

Table 128. TaiMed Biologics Inc Latest Developments

Table 129. United Biomedical Inc Basic Information, T Cell Surface Glycoprotein CD4 Manufacturing Base, Sales Area and Its Competitors

Table 130. United Biomedical Inc T Cell Surface Glycoprotein CD4 Product Offered

Table 131. United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. United Biomedical Inc Main Business

Table 133. United Biomedical Inc Latest Developments

List of Figures

Figure 1. Picture of T Cell Surface Glycoprotein CD4

Figure 2. T Cell Surface Glycoprotein CD4 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global T Cell Surface Glycoprotein CD4 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. T Cell Surface Glycoprotein CD4 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Forigerimod Acetate

Figure 10. Product Picture of HIV Vaccine 2

Figure 11. Product Picture of Ibalizumab

Figure 12. Product Picture of Others

Figure 13. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type in 2021

Figure 14. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2017-2022)

Figure 15. T Cell Surface Glycoprotein CD4 Consumed in HIV

Figure 16. Global T Cell Surface Glycoprotein CD4 Market: HIV (2017-2022) & (K Pcs)

Figure 17. T Cell Surface Glycoprotein CD4 Consumed in AIDS

Figure 18. Global T Cell Surface Glycoprotein CD4 Market: AIDS (2017-2022) & (K Pcs)

Figure 19. T Cell Surface Glycoprotein CD4 Consumed in GVHD

Figure 20. Global T Cell Surface Glycoprotein CD4 Market: GVHD (2017-2022) & (K Pcs)

Figure 21. T Cell Surface Glycoprotein CD4 Consumed in SARS

Figure 22. Global T Cell Surface Glycoprotein CD4 Market: SARS (2017-2022) & (K Pcs)

Figure 23. T Cell Surface Glycoprotein CD4 Consumed in Others

Figure 24. Global T Cell Surface Glycoprotein CD4 Market: Others (2017-2022) & (K Pcs)

Figure 25. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2017-2022)

Figure 26. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application in 2021

Figure 27. T Cell Surface Glycoprotein CD4 Revenue Market by Company in 2021 ($ Million)

Figure 28. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Company in 2021

Figure 29. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Geographic Region in 2021

Figure 31. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2017-2022)

Figure 32. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Country/Region in 2021

Figure 33. Americas T Cell Surface Glycoprotein CD4 Sales 2017-2022 (K Pcs)

Figure 34. Americas T Cell Surface Glycoprotein CD4 Revenue 2017-2022 ($ Millions)

Figure 35. APAC T Cell Surface Glycoprotein CD4 Sales 2017-2022 (K Pcs)

Figure 36. APAC T Cell Surface Glycoprotein CD4 Revenue 2017-2022 ($ Millions)

Figure 37. Europe T Cell Surface Glycoprotein CD4 Sales 2017-2022 (K Pcs)

Figure 38. Europe T Cell Surface Glycoprotein CD4 Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales 2017-2022 (K Pcs)

Figure 40. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue 2017-2022 ($ Millions)

Figure 41. Americas T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2021

Figure 42. Americas T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2021

Figure 43. United States T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC T Cell Surface Glycoprotein CD4 Sales Market Share by Region in 2021

Figure 48. APAC T Cell Surface Glycoprotein CD4 Revenue Market Share by Regions in 2021

Figure 49. China T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 53. India T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2021

Figure 56. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2021

Figure 57. Germany T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 58. France T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2021

Figure 63. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2021

Figure 64. Egypt T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country T Cell Surface Glycoprotein CD4 Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of T Cell Surface Glycoprotein CD4 in 2021

Figure 70. Manufacturing Process Analysis of T Cell Surface Glycoprotein CD4

Figure 71. Industry Chain Structure of T Cell Surface Glycoprotein CD4

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles